Rock Springs Capital Management LP Cullinan Oncology, Inc. Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
A detailed history of Rock Springs Capital Management LP transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 742,114 shares of CGEM stock, worth $6.63 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
742,114
Previous 736,914
0.71%
Holding current value
$6.63 Million
Previous $12.3 Million
26.73%
% of portfolio
0.36%
Previous 0.42%
Shares
7 transactions
Others Institutions Holding CGEM
# of Institutions
153Shares Held
67.1MCall Options Held
41.1KPut Options Held
112K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$68.3 Million13.93% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$51.4 Million2.62% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$31.7 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$30.5 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$30.2 Million1.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $407M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...